{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T21:22:17Z","timestamp":1787433737862,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bbadis.2026.168384","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:44:14Z","timestamp":1785167054000},"page":"168384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The m6A reader IGF2BP2 promotes hepatic fibrosis by stabilizing AEBP1 mRNA and regulating GRB2-mediated hepatic stellate cell activation"],"prefix":"10.1016","volume":"1872","author":[{"given":"Youwen","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2026.168384_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25147873","article-title":"Liver fibrosis: from basic science towards clinical progress, focusing on the central role of hepatic stellate cells","volume":"25","author":"Akk\u0131z","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2026.168384_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bbadis.2026.168384_bb0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.bbadis.2026.168384_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136777","article-title":"Liver disease: induction, progression, immunological mechanisms, and therapeutic interventions","volume":"22","author":"Neshat","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2026.168384_bb0025","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2026.168384_bb0030","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jconrel.2024.10.012","article-title":"Nano-encapsulation of drugs to target hepatic stellate cells: toward precision treatments of liver fibrosis","volume":"376","author":"Yuan","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbadis.2026.168384_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110413","article-title":"Study on the relationship between hepatic fibrosis and epithelial-mesenchymal transition in intrahepatic cells","volume":"129","author":"Chen","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbadis.2026.168384_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1198","article-title":"ALKBH5-mediated m6 A demethylation of TIRAP mRNA promotes radiation-induced liver fibrosis and decreases radiosensitivity of hepatocellular carcinoma","volume":"13","author":"Chen","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbadis.2026.168384_bb0045","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1042\/BST20230574","article-title":"RNA m6A modification, signals for degradation or stabilisation?","volume":"52","author":"Wei","year":"2024","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbadis.2026.168384_bb0050","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.gendis.2023.02.054","article-title":"Decoding m6A mRNA methylation by reader proteins in liver diseases","volume":"11","author":"Sun","year":"2024","journal-title":"Genes Dis."},{"key":"10.1016\/j.bbadis.2026.168384_bb0055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41419-024-06509-9","article-title":"The m6A reader IGF2BP2 regulates glycolytic metabolism and mediates histone lactylation to enhance hepatic stellate cell activation and liver fibrosis","volume":"15","author":"Zhou","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2026.168384_bb0060","doi-asserted-by":"crossref","first-page":"8097872","DOI":"10.1155\/2020\/8097872","article-title":"AEBP1 is a novel oncogene: mechanisms of action and signaling pathways","volume":"2020","author":"Majdalawieh","year":"2020","journal-title":"J. Oncol."},{"key":"10.1016\/j.bbadis.2026.168384_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.143554","article-title":"AEBP1 or ACLP, which is the key factor in inflammation and fibrosis?","volume":"310","author":"Runtian","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbadis.2026.168384_bb0070","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3108933","article-title":"AEBP1 is one of the epithelial-mesenchymal transition regulatory genes in colon adenocarcinoma","volume":"2021","author":"Li","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bbadis.2026.168384_bb0075","doi-asserted-by":"crossref","first-page":"255","DOI":"10.5551\/jat.49106","article-title":"AEBP1 promotes the occurrence and development of abdominal aortic aneurysm by modulating inflammation via the NF-\u03baB pathway","volume":"27","author":"Ren","year":"2020","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.bbadis.2026.168384_bb0080","first-page":"656","article-title":"Adipocyte enhancer binding protein 1 exacerbates myocardial ischaemia-reperfusion injury via inhibition of I\u03baB\u03b1","volume":"83","author":"Xue","year":"2024","journal-title":"Folia Morphol. (Warsz.)"},{"key":"10.1016\/j.bbadis.2026.168384_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219764","article-title":"AEBP1 expression increases with severity of fibrosis in NASH and is regulated by glucose, palmitate, and miR-372-3p","volume":"14","author":"Gerhard","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2026.168384_bb0090","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/1751-2980.13230","article-title":"Fibroblast-specific adipocyte enhancer binding protein 1 is a potential pathological trigger and prognostic marker for liver fibrosis independent of etiology","volume":"24","author":"Zhang","year":"2023","journal-title":"J. Dig. Dis."},{"key":"10.1016\/j.bbadis.2026.168384_bb0095","article-title":"GRB2: a dynamic adaptor protein orchestrating cellular signaling in health and disease","volume":"39","author":"Malagrin\u00f2","year":"2024","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.bbadis.2026.168384_bb0100","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-30562-7","article-title":"GRB2 dimerization mediated by SH2 domain-swapping is critical for T cell signaling and cytokine production","volume":"13","author":"Sandouk","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2026.168384_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15164179","article-title":"The role of GAB1 in cancer","volume":"15","author":"P\u00e9rez-Baena","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.bbadis.2026.168384_bb0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13046-019-1025-2","article-title":"Elevated expression of Gab1 promotes breast cancer metastasis by dissociating the PAR complex","volume":"38","author":"Wang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2026.168384_bb0115","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.biopha.2017.05.142","article-title":"Role of growth factor receptor-bound 2 in CCl4-induced hepatic fibrosis","volume":"92","author":"Ge","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbadis.2026.168384_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121861","article-title":"Grb2-related adaptor protein GRAP is a novel regulator of liver fibrosis","volume":"327","author":"Wu","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2026.168384_bb0125","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nprot.2015.017","article-title":"High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers","volume":"10","author":"Mederacke","year":"2015","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbadis.2026.168384_bb0130","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1158\/1541-7786.MCR-11-0488","article-title":"Identification of genomic targets of transcription factor AEBP1 and its role in survival of glioma cells","volume":"10","author":"Ladha","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbadis.2026.168384_bb0135","doi-asserted-by":"crossref","first-page":"100972","DOI":"10.1016\/j.neo.2024.100972","article-title":"AEBP1 promotes papillary thyroid cancer progression by activating BMP4 signaling","volume":"49","author":"Ju","year":"2024","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbadis.2026.168384_bb0140","doi-asserted-by":"crossref","first-page":"14736","DOI":"10.1038\/s41598-025-99685-3","article-title":"GRB2 promotes brain metastasis in HER2-positive breast cancer by regulating the Ras\/MAPK pathway","volume":"15","author":"Li","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2026.168384_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010696","article-title":"Disabled-2 (DAB2): a key regulator of anti- and pro-tumorigenic pathways","volume":"24","author":"Price","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2026.168384_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2023.101231","article-title":"Liver fibrosis in NAFLD\/NASH: from pathophysiology towards diagnostic and therapeutic strategies","volume":"95","author":"Parola","year":"2024","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.bbadis.2026.168384_bb0155","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.3748\/wjg.v20.i23.7312","article-title":"Pathogenesis of liver cirrhosis","volume":"20","author":"Zhou","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2026.168384_bb0160","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1016\/j.ymthe.2022.07.020","article-title":"The m6A methyltransferase Mettl3 deficiency attenuates hepatic stellate cell activation and liver fibrosis","volume":"30","author":"Li","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbadis.2026.168384_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1793","article-title":"The IGF2BP3\/Notch\/Jag1 pathway: a key regulator of hepatic stellate cell ferroptosis in liver fibrosis","volume":"14","author":"Li","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbadis.2026.168384_bb0170","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3892\/or.2025.9002","article-title":"m6A reader IGF2BP2 mediates paclitaxel resistance in esophageal squamous cell carcinoma via FOXM1 mRNA stabilization","volume":"54","author":"Ren","year":"2025","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbadis.2026.168384_bb0175","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12935-025-03736-8","article-title":"The m6A reader IGF2BP2 promotes pancreatic cancer progression through the m6A-SLC1A5-mTORC1 axis","volume":"25","author":"Pu","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbadis.2026.168384_bb0180","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.ccell.2022.10.004","article-title":"The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia","volume":"40","author":"Weng","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbadis.2026.168384_bb0185","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41698-025-00958-x","article-title":"m6A reader IGF2BP2-stabilized lncRNA LHX1-DT inhibits renal cell carcinoma (RCC) cell proliferation and invasion by sponging miR-590-5p","volume":"9","author":"Zhu","year":"2025","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.bbadis.2026.168384_bb0190","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/jcb.25116","article-title":"MicroRNA-19b reduces hepatic stellate cell proliferation by targeting GRB2 in hepatic fibrosis models in vivo and in vitro as part of the inhibitory effect of estradiol","volume":"116","author":"Ge","year":"2015","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbadis.2026.168384_bb0195","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe9254","article-title":"GRB2 enforces homology-directed repair initiation by MRE11","volume":"7","author":"Ye","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbadis.2026.168384_bb0200","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1038\/s41467-024-46283-y","article-title":"GRB2 stabilizes RAD51 at reversed replication forks suppressing genomic instability and innate immunity against cancer","volume":"15","author":"Ye","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2026.168384_bb0205","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1042\/bj20030668","article-title":"Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling","volume":"376","author":"Zhang","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2026.168384_bb0210","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70905","article-title":"GRB2 promotes malignant behaviors of breast cancer by modulating the global expression and alternative splicing profiles in SK-BR-3 cells through binding mRNA","volume":"14","author":"Liu","year":"2025","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbadis.2026.168384_bb0215","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/carcin\/bgm245","article-title":"Grb2 binding to Tyr284 in TbetaR-II is essential for mammary tumor growth and metastasis stimulated by TGF-beta","volume":"29","author":"Galliher-Beckley","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbadis.2026.168384_bb0220","doi-asserted-by":"crossref","DOI":"10.1038\/srep15688","article-title":"TGF-\u03b22 induces Grb2 to recruit PI3-K to TGF-RII that activates JNK\/AP-1-signaling and augments invasiveness of Theileria-transformed macrophages","volume":"5","author":"Haidar","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2026.168384_bb0225","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022053","article-title":"Signaling receptors for TGF-\u03b2 family members","volume":"8","author":"Heldin","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bbadis.2026.168384_bb0230","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.4049\/jimmunol.2100218","article-title":"FCRL1 regulates B cell receptor-induced ERK activation through GRB2","volume":"207","author":"DeLuca","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2026.168384_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217195","article-title":"N6-methyladenosine enhances the expression of TGF-\u03b2-SMAD signaling family to inhibit cell growth and promote cell metastasis","volume":"603","author":"Peng","year":"2024","journal-title":"Cancer Lett."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926002474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926002474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T20:24:50Z","timestamp":1787430290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443926002474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0925443926002474"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168384","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The m6A reader IGF2BP2 promotes hepatic fibrosis by stabilizing AEBP1 mRNA and regulating GRB2-mediated hepatic stellate cell activation","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168384","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"168384"}}